ReP USP - Resultado da busca

Artigo de periodico
Advances in lyotropic liquid crystal systems for skin drug delivery (2020)
Silvestrini, Ana Vitória Pupo ; Caron, Angelo Luis ; Viegas, Juliana Santos Rosa ; Praça, Fabíola Silva Garcia ; Bentley, Maria Vitória Lopes Badra
Source: Expert Opinion on Drug Delivery. Unidade: FCFRP
Subjects: CARCINOGÊNESE, DIFERENCIAÇÃO CELULAR, REGULAÇÃO GÊNICA, PROTEÍNAS DO TECIDO NERVOSO, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRINI, Ana Vitória Pupo et al. Advances in lyotropic liquid crystal systems for skin drug delivery. Expert Opinion on Drug Delivery, v. 17, n. 12, p. 1781-1805, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425247.2020.1819979. Acesso em: 08 maio 2024.
APA
Silvestrini, A. V. P., Caron, A. L., Viegas, J. S. R., Praça, F. S. G., & Bentley, M. V. L. B. (2020). Advances in lyotropic liquid crystal systems for skin drug delivery. Expert Opinion on Drug Delivery, 17( 12), 1781-1805. doi:10.1080/17425247.2020.1819979
NLM
Silvestrini AVP, Caron AL, Viegas JSR, Praça FSG, Bentley MVLB. Advances in lyotropic liquid crystal systems for skin drug delivery [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 12): 1781-1805.[citado 2024 maio 08 ] Available from: https://doi.org/10.1080/17425247.2020.1819979
Vancouver
Silvestrini AVP, Caron AL, Viegas JSR, Praça FSG, Bentley MVLB. Advances in lyotropic liquid crystal systems for skin drug delivery [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 12): 1781-1805.[citado 2024 maio 08 ] Available from: https://doi.org/10.1080/17425247.2020.1819979
Artigo de periodico
Nanocarriers: more than tour de force for thymoquinone (2020)
Rathore, Charul; Rathbone, Michael J; Chellappan, Dinesh Kumar; Tambuwala, Murtaza M ; Pinto, Terezinha de Jesus Andreoli ; Dureja, Harish; Hemrajani, Chetna; Gupta, Gaurav ; Dua, Kamal; Negi, Poonam
Source: Expert Opinion on Drug Delivery. Unidade: FCF
Subjects: NANOPARTÍCULAS, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RATHORE, Charul et al. Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, v. 17, n. 4, p. 479-494, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425247.2020.1730808. Acesso em: 08 maio 2024.
APA
Rathore, C., Rathbone, M. J., Chellappan, D. K., Tambuwala, M. M., Pinto, T. de J. A., Dureja, H., et al. (2020). Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, 17( 4), 479-494. doi:10.1080/17425247.2020.1730808
NLM
Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2024 maio 08 ] Available from: https://doi.org/10.1080/17425247.2020.1730808
Vancouver
Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2024 maio 08 ] Available from: https://doi.org/10.1080/17425247.2020.1730808
Artigo de periodico
SLN and NLC for topical, dermal, and transdermal drug delivery (2020)
Souto, Eliana B.; Baldim, Iara ; Oliveira, Wanderley Pereira de ; Rao, Rekha; Yadav, Nitesh; Gama, Francisco M.; Mahant, Sheefali
Source: Expert Opinion on Drug Delivery. Unidade: FCFRP
Subjects: NANOPARTÍCULAS, LIPÍDEOS, PELE, SURFACTANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUTO, Eliana B. et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opinion on Drug Delivery, v. 17, n. 3, p. 357-377, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425247.2020.1727883. Acesso em: 08 maio 2024.
APA
Souto, E. B., Baldim, I., Oliveira, W. P. de, Rao, R., Yadav, N., Gama, F. M., & Mahant, S. (2020). SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opinion on Drug Delivery, 17( 3), 357-377. doi:10.1080/17425247.2020.1727883
NLM
Souto EB, Baldim I, Oliveira WP de, Rao R, Yadav N, Gama FM, Mahant S. SLN and NLC for topical, dermal, and transdermal drug delivery [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 3): 357-377.[citado 2024 maio 08 ] Available from: https://doi.org/10.1080/17425247.2020.1727883
Vancouver
Souto EB, Baldim I, Oliveira WP de, Rao R, Yadav N, Gama FM, Mahant S. SLN and NLC for topical, dermal, and transdermal drug delivery [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 3): 357-377.[citado 2024 maio 08 ] Available from: https://doi.org/10.1080/17425247.2020.1727883
Artigo de periodico
Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents (2017)
Maranhão, Raul Cavalcante ; Vital, Carolina Graziani; Tavani, Thauany Martins; Graziani, Silvia Regina
Source: Expert Opinion on Drug Delivery. Unidade: FCF
Subjects: QUIMIOTERAPIA, NEOPLASIAS, LIPOSSOMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante et al. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents. Expert Opinion on Drug Delivery, v. 14, n. 10, p. 1217-1226, 2017Tradução . . Disponível em: https://doi.org/10.1080/17425247.2017.1276560. Acesso em: 08 maio 2024.
APA
Maranhão, R. C., Vital, C. G., Tavani, T. M., & Graziani, S. R. (2017). Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents. Expert Opinion on Drug Delivery, 14( 10), 1217-1226. doi:10.1080/17425247.2017.1276560
NLM
Maranhão RC, Vital CG, Tavani TM, Graziani SR. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents [Internet]. Expert Opinion on Drug Delivery. 2017 ; 14( 10): 1217-1226.[citado 2024 maio 08 ] Available from: https://doi.org/10.1080/17425247.2017.1276560
Vancouver
Maranhão RC, Vital CG, Tavani TM, Graziani SR. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents [Internet]. Expert Opinion on Drug Delivery. 2017 ; 14( 10): 1217-1226.[citado 2024 maio 08 ] Available from: https://doi.org/10.1080/17425247.2017.1276560
Artigo de periodico
Advances in non-invasive drug delivery for atherosclerotic heart disease (2015)
Maranhão, Raul Cavalcante ; Tavares, Elaine Rufo
Source: Expert Opinion on Drug Delivery. Unidade: FCF
Subjects: DOENÇAS CARDIOVASCULARES, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante e TAVARES, Elaine Rufo. Advances in non-invasive drug delivery for atherosclerotic heart disease. Expert Opinion on Drug Delivery, v. 12, n. 7, p. 1135-1147, 2015Tradução . . Disponível em: https://doi.org/10.1517/17425247.2015.999663. Acesso em: 08 maio 2024.
APA
Maranhão, R. C., & Tavares, E. R. (2015). Advances in non-invasive drug delivery for atherosclerotic heart disease. Expert Opinion on Drug Delivery, 12( 7), 1135-1147. doi:10.1517/17425247.2015.999663
NLM
Maranhão RC, Tavares ER. Advances in non-invasive drug delivery for atherosclerotic heart disease [Internet]. Expert Opinion on Drug Delivery. 2015 ; 12( 7): 1135-1147.[citado 2024 maio 08 ] Available from: https://doi.org/10.1517/17425247.2015.999663
Vancouver
Maranhão RC, Tavares ER. Advances in non-invasive drug delivery for atherosclerotic heart disease [Internet]. Expert Opinion on Drug Delivery. 2015 ; 12( 7): 1135-1147.[citado 2024 maio 08 ] Available from: https://doi.org/10.1517/17425247.2015.999663

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration